A LinkedIn post from Navina highlights commentary by the company’s VP of Value-Based Care, Dana McCalley, on the role of specialists in value-based care models. According to the post, McCalley argues in Medical Economics that specialists drive a substantial portion of healthcare spending yet are often evaluated using primary-care metrics and remain underrepresented in governance and incentive structures.
The post suggests that evolving value-based care will require models that treat specialists as full participants rather than cost items to be constrained. For investors, this emphasis on more collaborative care across primary and specialty settings points to potential demand for platforms and analytics that better integrate specialist data and incentives, a segment in which Navina is positioning its technology.
If such models gain traction, vendors able to support multi-specialty alignment may benefit from expanded adoption among payers and provider groups. Navina’s public engagement on this topic could indicate a strategic focus on enabling more comprehensive value-based arrangements, which may influence its competitive standing in the healthcare data and AI-enabled care management space.

